Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BioAge Labs, Inc. | 330,000 | reported | 17 Feb 2026 | tx 5+1,992,871−233,107 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Feb 2026 | GRANT_AWARD | BioAge Labs, Inc. | 330,000 | 0.00 USD | deriv |
| 13 Jan 2026 | SALE | BioAge Labs, Inc. | 233,107 | 18.12 USD | |
| 18 Feb 2025 | GRANT_AWARD | BioAge Labs, Inc. | 530,000 | 0.00 USD | deriv |
| 17 Apr 2024 | GRANT_AWARD | BioAge Labs, Inc. | 708,044 | 0.00 USD | deriv |
| 25 Sept 2024 | GRANT_AWARD | BioAge Labs, Inc. | 424,827 | 0.00 USD | deriv |